Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to discuss China's DeepSeek AI development, impact on the AI technology race, AI investment outlook,
LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology luminary Peter Thiel became friends as college students during the 1980s.
LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new treatments for cancer.
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an
The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.
Dedicated to spotlighting global leaders, the Tarnopol series serves as a platform for addressing critical societal issues, including AI’s potential and ethical implications.
What Could Possibly Go Right with Our AI Future," the LinkedIn co-founder makes the case that AI can extend human
LinkedIn co-founder Reid Hoffman and famed oncologist Dr. Siddhartha Mukherjee have raised a whopping $24.6 million in a seed funding round. The money will be used to launch their new artificial intelligence (AI) start-up, Manas AI.
Schools are facing cuts across Minnesota. Bloomington has an interesting plan. LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto ...
LinkedIn Founder Reid Hoffman Sees Bright AI Future and Hopes His Tech Peers Are Right About Trump LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in ...
Tech investor and LinkedIn co-founder Reid Hoffman is teaming up with cancer researcher Siddhartha Mukherjee on an artificial intelligence drug discovery startup that is launching with $24.6 million of initial funding.
The author of the seminal cancer biography The Emperor Of All Maladies and the co-founder of LinkedIn are looking to connect their skills to the development of new medicines by launching a new artificial intelligence-driven drug discovery outfit.